Topical beta-blockers for treatment of glaucoma and the risk of Parkinson's disease. Meshi A, Giladi N, Zahavi A, Gabbay IE, et al. Br J Ophthalmol 2025 Sep 3:bjo-2024-326689. doi: 10.1136/bjo-2024-326689.

Read + Share

Amedeo Smart

Independent Medical Education

Meshi A, Giladi N, Zahavi A, Gabbay IE, et al. Topical beta-blockers for treatment of glaucoma and the risk of Parkinson's disease. Br J Ophthalmol 2025 Sep 3:bjo-2024-326689. doi: 10.1136/bjo-2024-326689.
PMID: 40903198